Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.7900-0.1600 (-8.21%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-34,447
-21,243
-31,770
-31,039
-18,567
Depreciation & amortisation
344.338
502.48
388.221
111.453
0
Stock-based compensation
4,249
2,926
4,252
3,548
2,187
Change in working capital
-670.471
1,526
-212.152
-2,178
-235.504
Accounts payable
88.417
38.382
-577.105
209.193
862.676
Other working capital
-32,060
-16,133
-28,893
-30,425
-17,718
Other non-cash items
53.254
-497.025
-
-
-
Net cash provided by operating activities
-30,524
-16,038
-27,342
-29,557
-16,616
Cash flows from investing activities
Investments in property, plant and equipment
-1,537
-94.75
-1,551
-868.505
-1,103
Net cash used for investing activities
-1,537
-94.75
-1,551
-868.505
-1,103
Cash flows from financing activities
Common stock issued
404.555
5,125
11,640
28,015
24,280
Common stock repurchased
-
-2.875
0
-
-
Other financing activities
-114.28
-108.7
-
-
-
Net cash used provided by (used for) financing activities
414.74
5,013
11,751
28,885
24,995
Net change in cash
-31,569
-11,134
-17,182
-1,506
7,206
Cash at beginning of period
44,716
16,612
33,795
35,301
28,095
Cash at end of period
13,070
5,478
16,612
33,795
35,301
Free cash flow
Operating cash flow
-30,524
-16,038
-27,342
-29,557
-16,616
Capital expenditure
-1,537
-94.75
-1,551
-868.505
-1,103
Free cash flow
-32,060
-16,133
-28,893
-30,425
-17,718